Search research articles
Contact Us
Filters
Showing results (41-50 of 67) with videos related to
Page
of 7
Sort By:
BMC Infectious Diseases
|
July 4, 2014
Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012
Hongjo Choi, Myungsun Lee, Ray Y Chen, et al.
Ebiomedicine
|
February 13, 2016
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Taeksun Song, Myungsun Lee, Han-Seung Jeon, et al.
Nature Medicine
|
December 8, 2017
Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Science Translational Medicine
|
December 5, 2014
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
M Teresa Coleman, Ray Y Chen, Myungsun Lee, et al.
EJNMMI Research
|
June 27, 2018
A semi-automatic technique to quantify complex tuberculous lung lesions on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computerised tomography images
Stephanus T Malherbe, Patrick Dupont, Ilse Kant, et al.
ERJ Open Research
|
March 11, 2026
Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis
Munyaradzi Musvosvi, Elisa Nemes, Michele Tameris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 8, 2015
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058
David S Metzger, Deborah Donnell, David D Celentano, et al.
Nature Medicine
|
February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
Andreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Plos One
|
February 14, 2013
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients
Hui Xing, Yuhua Ruan, Jingyun Li, et al.
The Lancet. Microbe
|
October 7, 2021
Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis
Ray Y Chen, Xiang Yu, Bronwyn Smith, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 67) with videos related to
Sort By:
Page
of 7
BMC Infectious Diseases
|
July 4, 2014
Predictors of pulmonary tuberculosis treatment outcomes in South Korea: a prospective cohort study, 2005-2012
Hongjo Choi, Myungsun Lee, Ray Y Chen, et al.
Ebiomedicine
|
February 13, 2016
Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis
Taeksun Song, Myungsun Lee, Han-Seung Jeon, et al.
Nature Medicine
|
December 8, 2017
Corrigendum: Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T Malherbe, Shubhada Shenai, Katharina Ronacher, et al.
Science Translational Medicine
|
December 5, 2014
PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis
M Teresa Coleman, Ray Y Chen, Myungsun Lee, et al.
EJNMMI Research
|
June 27, 2018
A semi-automatic technique to quantify complex tuberculous lung lesions on <sup>18</sup>F-fluorodeoxyglucose positron emission tomography/computerised tomography images
Stephanus T Malherbe, Patrick Dupont, Ilse Kant, et al.
ERJ Open Research
|
March 11, 2026
Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis
Munyaradzi Musvosvi, Elisa Nemes, Michele Tameris, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
January 8, 2015
Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058
David S Metzger, Deborah Donnell, David D Celentano, et al.
Nature Medicine
|
February 16, 2024
A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial
Andreas H Diacon, Clifton E Barry, Alex Carlton, et al.
Plos One
|
February 14, 2013
HIV drug resistance and its impact on antiretroviral therapy in Chinese HIV-infected patients
Hui Xing, Yuhua Ruan, Jingyun Li, et al.
The Lancet. Microbe
|
October 7, 2021
Radiological and functional evidence of the bronchial spread of tuberculosis: an observational analysis
Ray Y Chen, Xiang Yu, Bronwyn Smith, et al.
Page
of 7